Clinical trial

SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response

NCT07129187

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-01

PhasePHASE2

Study timeline

Study start (estimated)2025-10-01Date precision: month

Registry last updated2025-08-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Early Breast Cancerunresolved

HER2 + Breast Cancerunresolved

Stage II Breast Cancerunresolved

Stage III Breast Cancerunresolved

Interventions

SHR-A1811DRUG

Sponsors & collaborators

Chuan Wanglead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07129187 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.